| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Sep'17 |
|---|---|---|---|---|---|---|---|---|---|
REVENUE | |||||||||
Total revenue | |||||||||
0 | - | - | - | - | - | - | - | - | - |
OPERATING EXPENSES | |||||||||
Research and development | |||||||||
32,343 | 30,656 | 27,244 | 20,818 | 15,110 | 11,079 | 0 | 0 | 0 | 0 |
General and administrative | |||||||||
10,945 | 10,385 | 9,742 | 9,686 | 8,578 | 6,864 | 0 | 0 | 0 | 0 |
Total operating expenses | |||||||||
43,288 | 41,041 | 36,986 | 30,504 | 23,688 | 17,943 | 0 | 0 | 0 | 0 |
LOSS FROM OPERATIONS | |||||||||
-42,267 | -41,041 | -36,986 | -30,504 | -23,688 | -17,943 | 0 | 0 | 0 | 0 |
OTHER INCOME (EXPENSE), NET: | |||||||||
Interest income | |||||||||
1,224 | 1,500 | 1,609 | 1,295 | 944 | 569 | 0 | 0 | 0 | 0 |
Interest expense | |||||||||
0 | - | 0 | - | - | - | 0 | - | - | - |
Other expense, net | |||||||||
0 | - | 0 | 0 | - | -159 | 0 | 0 | 0 | 0 |
Total other income (expense), net | |||||||||
381 | 935 | 1,332 | 1,137 | 780 | 408 | 0 | 0 | 0 | 0 |
Loss before income taxes | |||||||||
-41,886 | -40,106 | -35,654 | -29,367 | -22,908 | -17,535 | 0 | 0 | 0 | 0 |
Income tax provision | |||||||||
- | 22 | 70 | 108 | 106 | 86 | 0 | 0 | 0 | 0 |
Net loss | |||||||||
-41,886 | -40,128 | -35,724 | -29,475 | -23,014 | -17,621 | 0 | 0 | 0 | 0 |
Net loss attributable to common stockholders—basic and diluted (Note 10) | |||||||||
- | - | -24,539 | -22,242 | - | - | 0 | 0 | 0 | 0 |
Net loss per share—basic and diluted | |||||||||
-0.41 | -0.51 | -0.48 | -0.45 | -0.34 | 7.93 | -4.03 | -4.19 | -2.75 | -1.55 |
Weighted-average common stock outstanding—basic and diluted | |||||||||
23,175 | 22,941 | 22,677 | 22,479 | 22,313 | 17,318 | 2,138 | 1,962 | 1,787 | 1,483 |